Overview |
bs-3697R-PE-Cy5.5 |
CTR9 Polyclonal Antibody, PE-Cy5.5 Conjugated |
WB |
Human |
Mouse, Rat, Dog, Cow, Sheep, Pig, Horse, Chicken |
Specifications |
PE-Cy5.5 |
Rabbit |
KLH conjugated synthetic peptide derived from human CTR9 |
751-850/1173 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
9646 |
Nucleus |
SH2BP1; TSBP; Ctr 9; Ctr9; Ctr9 Paf1/RNA polymerase II complex component, homolog; p150; RNA polymerase associated protein CTR9 homolog; SH2 binding phosphoprotein; SH2 domain binding protein 1 tetratricopeptide repeat containing; TPR containing SH2 binding phosphoprotein; Paf1/RNA polymerase II complex component homolog Ctr9; SH2 domain binding protein 1; CTR9_HUMAN. |
CTR9 is a component of the PAF (polymerase-associated factor) complex which interacts with histone-modifying enzymes and RNA polymerase II and plays a role in a number of transcription-related processes. Recent studies show that CTR9 can regulate IL-6-responsive gene transcription by influencing histone methylation. |
Application Dilution |
WB |
1:300-5000 |